Lynda J. Spelman, MB BS, FACD


Veracity Clinical Research

Suite 18, Level 1, 250 Ipswich Road
Woolloongabba, Queensland, Australia
07 3039 1311


Specialty: Dermatology


Research Interests: Actinic Keratoses, Atopic Dermatitis (Eczema), Basal Cell Carcinoma, Cutaneous Lupus, Psoriasis, Urticaria

Dr. Lynda Spelman has more than 20 years of experience in clinical dermatology.  Dr. Spelman practices in Queensland, Australia in a group practice that sees both paediatric and adult patients involving a broad range of dermatological conditions. She has a special interest in inflammatory skin disorders.

Dr. Spelman is an active member in the medical community.  Her present positions include Honorary Secretary and Consultant and Director of Clinical Services at the Queensland Institute of Dermatology where she specializes in geriatric dermatology. 

Dr. Spelman has conducted over 40 Clinical Trials since 1990, both as Principal Investigator and Sub-Investigator.  Dr. Spelman has conducted clinical trials for dermatologic conditions and diseases including atopic dermatitis, psoriasis, and urticaria. 


Click to view Dr. Lynda Spelman's Publications

Zallmann M, Smith PK, Tang MLK, Spelman LJ, Cahill JL, Wortmann G, Katelaris CH, Allen KJ, Su JC. Debunking the Myth of Wool Allergy: Reviewing the Evidence for Immune and Non-immune Cutaneous Reactions. Acta Derm Venereol 2017 Aug 31; 97(8): 906-15. PMID: 28350041 / doi: 10.2340/00015555-2655

Papp K, Bachelez H, Costanzo A, Foley P, Gooderham M, Kaur P, Philipp S, Spelman L, Zhang N, Strober B. Clinical Similarity of the Biosimilar ABP 501 Compared With Adalimumab After Single Transition: Long-Term Results From a Randomised, Double-Blind, 52-Week, Phase 3 Study in Moderate-to-Severe Plaque Psoriasis Patients. Br J Dermatol 2017 Jul 28 [Epub ahead of print]. PMID: 28755394 / doi: 10.1111/bjd.15857

Papp K, Bachelez H, Costanzo A, Foley P, Gooderham M, Kaur P, Narbutt J, Philipp S, Spelman L, Weglowska J, Zhang N, Strober B. Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study. J Am Acad Dermatol 2017 Jun; 76(6): 1093-1102. Epub 2017 Mar 11. PMID: 28291552 / doi: 10.1016/j.jaad.2016.12.014

Johnston JJ, Spelman L. Pressure-induced localised granuloma annulare following use of an elbow splint. Prosthet Orthot Int 2017 Jun; 41(3): 311-13. Epub 2016 Sep 9. PMID: 27613591

Zallmann M, Smith PK, Tang ML, Spelman LJ, Cahill JL, Wortmann G, Katelaris CH, Allen KJ, Su JC. Debunking the myth of wool allergy: reviewing the evidence for immune and non-immune cutaneous reactions. Acta Derm Venereol 2017 Mar 28 [Epub ahead of print]. PMID: 28350041 / doi: 10.2340/00015555-2655

Selmer J, Skov T, Spelman L, Weedon D. SCCs and KAs are biologically distinct and can be diagnosed by light microscopy. Histopathology 2016 Oct; 69(4): 535-41. Epub 2016 Aug 16. PMID: 27323251 / doi: 10.1111/his.13018

See JA, Shumack S, Murrell DF, Rubel DM, Fernández-Peñas P, Salmon R, Hewitt D, Foley P, Spelman L. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia. Australas J Dermatol 2016 Aug; 57(3): 167-74. Epub 2015 May 31. PMID: 26033230 / doi: 10.1111/ajd.12354

Spelman L, Holland T, Davidson K. Daylight-mediated photodynamic therapy for actinic keratosis. Journal of the Dermatology Nurses’ Association 2016 Jul/Aug; 8(4): 265-8.

Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, Reich K, Amato D, Ball SG, Braun DK, Cameron GS, Erickson J, Konrad RJ, Muram TM, Nickoloff BJ, Osuntokun OO, Secrest RJ, Zhao F, Mallbris L, Leonardi CL; UNCOVER-1 Study Group; UNCOVER-2 Study Group; UNCOVER-3 Study Group. Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis. N Engl J Med 2016 Jul 28; 375(4): 345-56. Epub 2016 Jun 8. PMID: 27299809 / doi: 10.1056/NEJMoa1512711

Zane LT, Chanda S, Jarnagin K, Nelson DB, Spelman L, Gold LS. Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies. Immunotherapy 2016 Jul; 8(8): 853-66. Epub 2016 Jun 10. PMID: 27283509 / doi: 10.2217/imt-2016-0023

Spelman L, Rubel D, Murrell DF, See JA, Hewitt D, Foley P, Salmon R, Kerob D, Pascual T, Shumack S, Fernandez-Penas P. Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: evidence from a clinical and meteorological study. Australas J Dermatol 2016 Feb; 57(1): 24-8. Epub 2015 Mar 31. PMID: 25827200 / doi: 10.1111/ajd.12295

Stein Gold LF, Spelman L, Spellman MC, Hughes MH, Zane LT. A phase 2, randomized, controlled, dose-ranging study evaluating crisaborole topical ointment, 0.5% and 2% in adolescents with mild to moderate atopic dermatitis. J Drugs Dermatol 2015 Dec 1; 14(12): 1394-9. PMID: 26659931

Spelman L, Su JC, Fernandez-Peñas P, Varigos GA, Cooper AJ, Baker CS, Lee M, Ring JM, Thirunavukkarasu K. Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice. J Eur Acad Dermatol Venereol 2015 Nov; 29(11): 2184-91. Epub 2015 Sep 14. PMID: 26370225 / doi: 10.1111/jdv.13210

Murrell DF, Gebauer K, Spelman L, Zane LT. Crisaborole topical ointment, 2% in adults with atopic dermatitis: a phase 2a, vehicle-controlled, proof-of-concept study. J Drugs Dermatol 2015 Oct 1; 14(10): 1108-12. PMID: 26461821

Lebwohl M, Strober B, Menter A, Gordon K, Weglowska J, Puig L, Papp K, Spelman L, Toth D, Kerdel F, Armstrong AW, Stingl G, Kimball AB, Bachelez H, Wu JJ, Crowley J, Langley RG, Blicharski T, Paul C, Lacour JP, Tyring S, Kircik L, Chimenti S, Callis Duffin K, Bagel J, Koo J, Aras G, Li J, Song W, Milmont CE, Shi Y, Erondu N, Klekotka P, Kotzin B, Nirula A. Phase 3 studies comparing brodalumab with ustekinumab in psoriasis. N Engl J Med 2015 Oct; 373(14): 1318-28. PMID: 26422722 / doi: 10.1056/NEJMoa1503824

Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Lancet 2015 Aug 8; 386(9993): 541-51. Epub 2015 Jun 10. PMID: 26072109 / doi: 10.1016/S0140-6736(15)60125-8

Rubel DM, Spelman L, Murrell DF, See JA, Hewitt D, Foley P, Kerob D, Kerrouche N, Wulf HC, Shumack S. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial. Br J Dermatol 2014 Nov; 171(5): 1164-71. Epub 2014 Oct 20. PMID: 24861492 / doi: 10.1111/bjd.13138

Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C; the ERASURE and FIXTURE Study Groups. Secukinumab in plaque psoriasis – results of two phase 3 trials. N Engl J Med 2014 Jul 24; 371(4): 326-38. Epub 2014 Jul 9. PMID: 25007392 / doi: 10.1056/NEJMoa1314258

Rowe C, Spelman L, Oziemski M, Ryan A, Manoharan S, Wilson P, Daubney M, Scott J. Isotretinoin and mental health in adolescents: Australian consensus. Australas J Dermatol 2014 May; 55(2): 162-7. Epub 2013 Nov 28. PMID: 24283385 / doi: 10.1111/ajd.12117

Yoong C, Vun YY, Spelman L, Muir J.  True blue football fan: tattoo reaction confined to blue pigment.  Australas J Dermatol 2010 Feb; 51(1):21-22. PMID: 20148835 / doi: 10.1111/j.1440-0960.2009.00608.x

Kaufmann R, Spelman L, Weightman W, Reifenberger J, Szeimies RM, Verhaeghe E, Kerrouche N, Sorba V, Villemagne H, Rhodes LE. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities. Br J Dermatol 2008 May; 158(5): 994-999. Epub 13-Mar-2008.  PMID: 18341663

Hofman T, Cranswick N, Kuna P, Boznanski A, Latos T, Gold M, Murrell DF, Gebauer K, Behre U, Machura E, Olafsson J, Szalai Z, International Tacrolimus Ointment Study Group. Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. Arch Dis Child 2006 Nov; 91(11): 905-910. PMID: 16798785 / doi: 10.1136/adc.2006.094276

Noakes R, Spelman L, Williamson R. Is the L-tryptophan metabolite quinolinic acid responsible for eosinophilic fasciitis? Clin Exp Med 2006 Jun; 6(2): 60-64. PMID: 16820992

Vun Y, De’Ambrosis B, Spelman L, Muir JB, Yong-Gee S, Wagner G, Lun K. Seborrhoeic keratosis and malignancy: collision tumour or malignant transformation? Australas J Dermatol 2006 May; 47(2): 106-108. PMID: 16637805

Vinciullo C, Elliott T, Francis D, Gebauer K, Spelman L, Nguyen R, Weightman W, Sheridan A, Reid C, Czarnecki D, Murrell D. Photodynamic therapy with topical aminolaevulinate for ‘difficult-to-treat’ basal cell carcinoma. Br J Dermatology 2005 Apr; 152(4): 765-772. PMID: 15840111

Thai KE, Fergin P, Freeman M, Vinciullo C, Francis D, Spelman L, Murrell D, Anderson C, Weightman W, Reid C, Watson A, Foley P. A prospective study of the use of cryosurgery for the treatment of actinic keratosis. Int J Dermatol 2004 Sep; 43(9): 687-692. PMID: 15357755 

Noakes RR, Spelman L. Köbnerization in a woman with generalized lichen sclerosus. Australas J Dermatol 2004 May: 45(2): 144-145. PMID: 15068467

Martinez-Mir A, Glaser B, Chuang GS, Horev L, Waldman A, Engler DE, Gordon D, Spelman LJ, Hatzibougias I, Green J, Christiano AM, Zlotogorski A. Germline fumarate hydratase mutations in families with multiple cutaneous and uterine leiomyomata. J Invest Dermatol 2003 Oct; 121(4): 741-744. PMID: 14632190

Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P, Thai KE, Murrell D, Weightman W, Anderson C, Reid C, Watson A, Foley P. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003 Jun; 14(2): 99-106. PMID: 12775317

Spelman L, Dicker T. Aquagenic pruritus relieved by tight fitting clothing. Australas J Dermatol 2001 May; 42(2): 146. PMID: 11400693

Lun KR, Spelman LJ. Multiple piloleiomyomas. Australas J Dermatol 2000 Aug; 41(3): 185-186. PMID: 10954993

Novak C, Spelman L. Low energy fluence CO2 laser treatment of lymphangiectasia. Australas J Dermatol 1998 Nov; 39(4): 277-278. PMID: 9838733

Spelman LJ, Strutton GM, Robertson IM, Weedon D. Acquired ichthyosis in bone marrow transplant recipients. J Am Acad Dermatol 1996 Jul; 35(1): 17-20. PMID: 8682957

Spelman LJ, Robertson IM, Strutton GM, Weedon D. Pityriasis rosacea-like eruption after bone marrow transplantation. J Am Acad Dermatol 1994 Aug; 31(2 Pt 2): 348-351. PMID: 8034803

Duffy DL, Spelman LJ, Martin NG. Psoriasis in Australian twins. J Am Acad Dermatol 1993 Sep: 29(3): 428-434. PMID: 8349859

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.